Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion type Assertion NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_head.
- NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion description "[The ability to suppress the malignant phenotype by downregulating cyclin D1 expression may provide a new gene therapy approach for patients with malignant glioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_provenance.
- NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion evidence source_evidence_literature NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_provenance.
- NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion SIO_000772 21912938 NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_provenance.
- NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion wasDerivedFrom befree-20140225 NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_provenance.
- NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_assertion wasGeneratedBy ECO_0000203 NP489056.RAHS6tmnnBkfgseA7cH_vsfHdoKNer_0PVCyO5WwIr5fk130_provenance.